Revolutionizing Healthcare: The Emergence and Impact of Synthetic Data in Life Sciences

The realm of healthcare and life sciences is undergoing a transformative shift, fueled by the advent and integration of data-driven technologies. At the forefront of this revolution is the burgeoning use of synthetic data, a groundbreaking development poised to redefine … Read More

Women in Multiple Sclerosis

Women in Multiple Sclerosis webinar: take-home messages

In the Webinar: Women in Multiple Sclerosis, hosted by the Community of Practice of the BRAINTEASER project, we focused on the role of hormones on the onset and progression of the disease and delved deeply into several aspects of pregnancy. … Read More

The book 𝗧𝗼𝘄𝗮𝗿𝗱 𝗚𝗼𝗼𝗱 𝗦𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲 Published Open Access on Springer Nature

InSilicoTrials is thrilled to announce the publication of “𝙏𝙤𝙬𝙖𝙧𝙙 𝙂𝙤𝙤d 𝙎𝙞𝙢𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝙋𝙧𝙖𝙘𝙩𝙞𝙘𝙚 – Best practices for the use of computational modelling & simulation in the regulatory process of biomedical products ” a crucial document guiding the use of simulation data … Read More

Harnessing AI, Big Data, and the European Health Data Space for Revolutionary Advances in Research and Clinical Practice

At the Brain Innovation Days held in Brussels on October 26-27, 2023, organised by the European Brain Council, representatives from the BRAINTEASER project and from other pertinent initiatives gathered for a roundtable discussion. The focus was on promoting collaboration among various EU … Read More

The iDPP@CLEF Challenge as a Way to Open Science

iDPP@CLEF [1] is an open evaluation challenge to assess the performance of Artificial Intelligence (AI) algorithms to predict the progression of Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS). iDPP stands for Intelligent Disease Progression Prediction and it is a series of events, organised by the BRAINTEASER project, co-located with the Conference … Read More

Axoltis Pharma’s Breakthrough in Neurodegenerative Disease Research, Supported by InSilicoTrials

Axoltis Pharma is at the forefront of developing treatments for neurodegenerative diseases, with their phase 1b clinical trial of NX210c marking a notable achievement in the field. This peptide drug candidate has shown promising results following a successful phase 1a … Read More

AI state-of-play around clinical research – BRAINTEASER Community of Practice

The life sciences sector is beginning to experience the transformative effects of AI, with numerous applications offering clinical, operational, and medical advantages. Unlike other industries, life sciences face the unique challenge of safeguarding patient safety and privacy. This has led … Read More

Cutting-edge Big Data initiative seeks to provide crucial support to people affected by Amyotrophic Lateral Sclerosis and Multiple Sclerosis

Mamede de Carvalho, a renowned neurologist and the head of the Amyotrophic Lateral Sclerosis (ALS) Clinic at Centro Hospitalar Universitário Lisboa Norte (CHULN), situated at the prestigious Hospital de Santa Maria, recently unveiled the exciting BRAINTEASER project during an exclusive … Read More

Collaboration Between InSilicoTrials and Biofarma Group Explores the Benefits of In Silico Technology in Clinical Research

InSilicoTrials has collaborated effectively with Biofarma Group to harness the potential of in silico technology for clinical research. In this collaboration, InSilicoTrials utilized its expertise in computational modeling to analyze and reinterpret the clinical trial data of Epatrex, Biofarma Group’s … Read More

Cutting-edge Big Data initiative seeks to provide crucial support to people affected by Amyotrophic Lateral Sclerosis and Multiple Sclerosis

Mamede de Carvalho, a renowned neurologist and the head of the Amyotrophic Lateral Sclerosis (ALS) Clinic at Centro Hospitalar Universitário Lisboa Norte (CHULN), situated at the prestigious Hospital de Santa Maria, recently unveiled the exciting BRAINTEASER project during an exclusive … Read More

Start simulating now